Semnur Pharmaceuticals, Inc. Cash and Restricted Cash
Semnur Pharmaceuticals, Inc. (SMNR) had Cash and Restricted Cash of $39.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-10
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $39.00K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $103.00K.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $20.00K.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $85.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $39.00K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $103.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $20.00K 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $85.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $55.00K 10-Q · filed 2026-08-10 | $126.00 10-Q · filed 2025-08-15 |
| 2025-03-31 | $7.00K 10-Q · filed 2026-05-13 | $2.74K 10-Q · filed 2025-05-16 |
| 2024-12-31 | $12.00K 10-Q · filed 2026-08-10 | $16.87K 10-K · filed 2025-04-02 |
| 2024-09-30 | $13.00K 10-Q · filed 2025-11-12 | $14.29K 10-Q · filed 2024-11-19 |
| 2024-06-30 | $1.50K 10-Q · filed 2025-08-15 | |
| 2024-03-31 | $1.01K 10-Q · filed 2025-05-16 | |
| 2023-12-31 | $12.00K S-1 · filed 2026-05-12 | $204.46K 10-K · filed 2024-04-01 |
| 2023-09-30 | $13.46K 10-Q · filed 2024-11-19 | |
| 2023-06-30 | $9.13K 10-Q · filed 2024-08-19 | |
| 2023-03-31 | $579.35K 10-Q · filed 2024-05-22 | |
| 2022-12-31 | $819.75K 10-K · filed 2025-04-02 | |
| 2022-09-30 | $985.58K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $1.11M 10-Q · filed 2023-08-15 | |
| 2022-03-31 | $16.57K 10-Q · filed 2023-05-15 | |
| 2022-01-04 | $0.00 10-Q · filed 2023-05-15 |